Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Acorda Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q1 2022
- Shares held
- 6.65M
- +3.30M (+98.6%) vs. Q1 2022
- Total value
- $3.08M
- −$2.30M (−42.7%) vs. Q1 2022
- New holders
- 9
- 11 more added
- Sold out
- 7
- 6 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 2 | $8.00K |
| Q1 2024 | 17 | $2.13M |
| Q4 2023 | 15 | $2.33M |
| Q3 2023 | 16 | $2.30M |
| Q2 2023 | 15 | $1.94M |
| Q1 2023 | 30 | $3.71M |
| Q4 2022 | 36 | $4.09M |
| Q3 2022 | 36 | $1.91M |
| Q2 2022 | 35 | $3.08M |
| Q1 2022 | 34 | $5.42M |
| Q4 2021 | 34 | $9.48M |
| Q3 2021 | 36 | $14.7M |
| Q2 2021 | 37 | $18.1M |
| Q1 2021 | 37 | $18.0M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 11 | $0 | 0.00% | +3+37.5% | Added |
| Bank of America Corp | 1 | $0 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 293 | $0 | 0.00% | −43−12.8% | Reduced |
| IMA Wealth, Inc. | 17 | $0 | 0.00% | 00.0% | Unchanged |
| JNBA Financial Advisors | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | −84−98.8% | Reduced |
| Russell Investments Group, Ltd. | 6,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,351 | $2.00K | 0.00% | +552+11.5% | Added |
| Simplex Trading, LLC | 7,870 | $3.00K | 0.00% | +2,178+38.3% | Added |
| Verition Fund Management LLC | 13,641 | $6.00K | 0.00% | +13,641 | New |
| Ergoteles LLC | 13,300 | $6.00K | 0.00% | +13,300 | New |
| Simon Quick Advisors, LLC | 14,211 | $6.00K | 0.00% | +14,211 | New |
| Two Sigma Advisers, LP | 14,400 | $7.00K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,118 | $12.0K | 0.00% | −510−1.9% | Reduced |
| United Asset Strategies, Inc. | 27,100 | $13.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 28,698 | $13.0K | 0.00% | +25,883+919.5% | Added |
| Tower Research Capital LLC (TRC) | 27,234 | $13.0K | 0.00% | +26,655+4,603.6% | Added |
| Two Sigma Securities, LLC | 27,692 | $13.0K | 0.00% | +27,692 | New |
| State Street Corp | 31,648 | $15.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 39,319 | $18.0K | 0.00% | +39,319 | New |
| Geode Capital Management, LLC | 46,721 | $21.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 45,880 | $21.0K | 0.00% | +45,880 | New |
| Prudential Financial Inc | 60,200 | $28.0K | 0.00% | +60,200 | New |
| Wells Fargo & Company | 74,671 | $35.0K | 0.00% | +24,796+49.7% | Added |
| Bridgeway Capital Management, LLC | 101,706 | $47.0K | 0.00% | −142,384−58.3% | Reduced |
| HN Saltoro Capital, LP | 108,827 | $51.0K | 0.08% | +93,979+632.9% | Added |
| BlackRock Inc. | 139,522 | $66.0K | 0.00% | −25,952−15.7% | Reduced |
| Virtu Financial LLC | 145,318 | $68.0K | 0.01% | +145,318 | New |
| Vanguard Group Inc | 158,061 | $73.0K | 0.00% | −183,484−53.7% | Reduced |
| Millennium Management LLC | 311,509 | $145.0K | 0.00% | +270,588+661.2% | Added |
| Acadian Asset Management LLC | 682,670 | $318.0K | 0.00% | +214,931+46.0% | Added |
| Renaissance Technologies LLC | 901,318 | $420.0K | 0.00% | +194,100+27.4% | Added |
| Canyon Capital Advisors LLC | 1,193,988 | $556.0K | 0.04% | +544,957+84.0% | Added |
| Davidson Kempner Capital Management LP | 2,395,668 | $1.11M | 0.02% | +2,395,668 | New |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −464,276−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −19,752−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,505−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,658−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −755−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Private Capital Group, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |